Achillion Pharmaceuticals Inc. (ACHN) announced Monday morning that its ACH-4471 received a positive opinion from the European Medicines Agency's Committee for Orphan Medicinal Products for orphan status in the European Union.
from RTT - Before the Bell http://ift.tt/2oASfCV
via IFTTT
No comments:
Post a Comment